| Product NDC: | 0037-8110 |
| Proprietary Name: | MUSE |
| Non Proprietary Name: | Alprostadil |
| Active Ingredient(s): | 125 ug/1 & nbsp; Alprostadil |
| Administration Route(s): | URETHRAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0037-8110 |
| Labeler Name: | Meda Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020700 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110722 |
| Package NDC: | 0037-8110-01 |
| Package Description: | 6 POUCH in 1 CARTON (0037-8110-01) > 1 SUPPOSITORY in 1 POUCH (0037-8110-06) |
| NDC Code | 0037-8110-01 |
| Proprietary Name | MUSE |
| Package Description | 6 POUCH in 1 CARTON (0037-8110-01) > 1 SUPPOSITORY in 1 POUCH (0037-8110-06) |
| Product NDC | 0037-8110 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alprostadil |
| Dosage Form Name | SUPPOSITORY |
| Route Name | URETHRAL |
| Start Marketing Date | 20110722 |
| Marketing Category Name | NDA |
| Labeler Name | Meda Pharmaceuticals Inc. |
| Substance Name | ALPROSTADIL |
| Strength Number | 125 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |